Dublin, Sept. 13, 2017 (GLOBE NEWSWIRE) -- The "Global Cancer Photodynamic Therapy Market & Cancer Photosensitisers Clinical Trial Outlook 2023" report has been added to Research and Markets' offering.

Initially, the therapeutic property of Photodynamic Therapy was explored and limited to killing of microbes such as bacteria, fungi and viruses. It slowly evolved and was soon observed to be effective in the treatment of skin conditions such as acne and psoriasis further advancing to show effective results in complex conditions like atherosclerosis and herpes. Its impressive results in the above mentioned disease led scientists to explore its ability in the treatment of cancer which eventually led to a whole new segment of photodynamic therapy dedicated to the effective, noninvasive, safe and easier method of cancer treatment using light.

The photodynamic therapy market is currently segmented into four divisions of acne, cancer, atherosclerosis and psoriasis with acne and cancer currently leading with majority of research and development being focused in these aspects of the photodynamic therapy due to their steep demand. Recently, the Photodynamic therapy for various types of cancer like breast cancer, head and neck cancer and lung cancer has been receiving increased attention due to its innovative and noninvasive feature which is currently in high demand globally , that has further led to a steady growth in the photodynamic therapy market.

An insight into the global presence of photodynamic therapy shows that currently photodynamic therapy is widely being used in the developed countries like the UK, US and Russia. Unlike few years ago, when photodynamic therapy had just entered the market, it is currently found to be much more prevalent suggesting the steady growth of the photodynamic therapy market .several major hospitals in the US offer cancer treatment alternative using photodynamic therapy especially for the skin cancer related disease and lesion. This trend is bound to rise steadily with the increasing awareness among both the general public and the healthcare professionals

Currently, photodynamic therapy has shown promising results in the pre-clinical studied of prostate cancer, breast cancer, lung cancer, head and neck cancer and colorectal cancer. A few forms of cancers like the oesophageal cancer and colorectal cancer have been treated using photodynamic therapy in the developing countries, however majority of them are still under vigorous study in the clinical pipeline which is anticipated to be approved in a few years. Until then Photodynamic therapy has largely been approved and used in the palliative treatment of almost all types of cancer for the removal of residual tumor cells, thus prolonging the remission period of cancer.

The progress in the photodynamic therapy segment also suggests that someday it could help in the treatment of larger and deep tumors, which is currently not possible due to the low penetration of light. A technique known as interstitial therapy involving the use of imaging tests like computed tomography (CT) scans to guide fiber optics directly into tumors using needles is slowly developing. Early results in clinical and pre-clinical phase have shown that it could immensely helpful in the successful treatment of head and neck, prostate and liver tumors. Thus a thorough insight into the photodynamic therapy progress and its current scenario leads to the conclusion that photodynamic therapy deserves more attention and a central position in the treatment of cancer. It should be promoted and encouraged as part of a multimodal approach or a standalone treatment for early disease, palliative care or as a salvage treatment.

Key Topics Covered:

1. An Introductory Insight into Photodynamic Cancer Therapy
1.1 Overview
1.2 History & Evolution of the Photodynamic Cancer Therapy

2. Photodynamic Therapy - A Breakthrough in Modern Cancer Therapy
2.1 Dire Need for Photodynamic Therapy in Cancer Treatment - An Insight into its promising features
2.2 Superiority of Photodynamic Cancer Therapy over Traditional Cancer Therapy Method

3. Working Mechanism of the Photodynamic Cancer Therapy- It's Components & Their Role
3.1 Procedure for Photodynamic Therapy
3.2 Photosensitizers (PS) - A Crucial Component of the Photodynamic Therapy
3.2.1 Classification of Photosensitizers
3.2.2 Desired Features of an Effective Photosensitizer Agent
3.2.3 Photosensitizers Currently Used in Photodynamic Therapy
3.3 Oxygen - The Vital Substrate in Photodynamic Therapy
3.4 Light Source - For Safe & Effective Activation of the Photosensitizer

4. Photosensitizer Delivery - For Increased Efficacy of the Photodynamic Therapy
4.1 Organic Nano Particles Photosensitizer Delivery in Photo Dynamic therapy
4.2 Inorganic Nanocarrier of Photosensitizers in Photodynamic Therapy

5. Anti-Tumor Activity of the Photodynamic Therapy
5.1 Direct Tumor Photodynamic Therapy Damage
5.2 Vascular Damage
5.3 Inflammatory & Immune Response

6. Current Status of Various Cancer Treatments Using Photodynamic Therapy
6.1 Non-Melanoma Skin Cancer
6.2 Prostate Cancer
6.3 Breast Cancer
6.4 Brain Tumor
6.5 Lung Cancer
6.6 Head & Neck Cancer
6.7 Oral Lesions & Oesophageal Cancer
6.8 Cervical Cancer
6.9 Colorectal Cancer
6.10 Cancer of the Bile Duct and the Pancreas

7. Photodynamic Combinational Cancer Therapy- Overcoming Current Cancer Therapy Limitations

8. Recent & Promising Advances in the Photodynamic Therapy Segment
8.1 Intracellular Activated Two-Photon photodynamic Therapy for Breast Cancer
8.2 Gold Nano-Clusters: A New Nanotech Innovation for Photodynamic Therapy.
8.3 Photodynamic Therapy & Combinational Therapy using Microbial Adjuvants & Cytokines

9. Current Market Scenario of the Photodynamic Therapy & its Cognizance in the Oncology Segment
9.1 Global Photodynamic Therapy Market Analysis by Device & Essentials
9.2 Regional Analysis of the Photodynamic Therapy Market
9.2.1 North America
9.2.2 Europe
9.2.3 Asia Pacific
9.2.4 Latin America, Middle East & Africa

10. Favorable Factors for the Growth of Photodynamic Cancer Therapy Market
10.1 Rise in Global Cancer Incident
10.2 Increasing Awareness Regarding Photodynamic Therapy
10.3 Limitations & Failures of Existing Cancer Therapeutics
10.4 Advancement in Research & Development
10.5 Increasing Investment in the Photodynamic Therapy Segment
10.6 Presence of a Strong Clinical Pipeline
10.7 Approvals of the FDA

11. Challenges to the Photodynamic Therapy Market Growth
11.1 Technical & Scientific Limitations
11.2 Dominance of Conventional Therapeutics
11.3 Commercial Challenges
11.4 Patient Specific Issues
11.5 Side Effects Associated with the Photodynamic Therapy

12. Anticipation Regarding the Future of Photodynamic Cancer Therapy

13. Global Cancer Photosensitisers Clinical Pipeline by Company & Phase
13.1 Preclinical
13.2 Phase-I
13.3 Phase-I/II
13.4 Phase-II
13.5 Phase-III
13.6 Registered

14. Marketed Cancer Photosensitisers Clinical
14.1 Hexyl Aminolevulinate (Cevira, Cysview, Hexvix & Hexvix PDT)
14.2 Methyl Aminolevulinate (Metvix, Metvix PDT, Metvixia & Visonac)
14.3 Talaporfin (Aptocine, Aptocine, Aptocine & Litx)
14.4 Aminolevulinic Acid (Litx & Alaglio)
14.5 Aminolevulinic Acid (Alaglio, Effala, Gleolan & Gliolan)
14.6 Porfimer Sodium (Photobarr, Photofrin, Photofrin II & Photofrin PDT)
14.7 Methoxsalen Solution (UVADEX)
14.8 Temoporfin (Foscan)

15. Competitive Landscape
15.1 Theralase Technologies
15.2 Dusa Pharmaceuticals
15.3 Biofrontera AG
15.4 Soligenix
15.5 Coherent
15.6 Lumenis
15.7 Nanoprobes
15.8 PhotoMedex
15.9 Biolitec
15.10 Ambicare Health
15.11 Quest Pharma Tech
15.12 Photolitec

For more information about this report visit https://www.researchandmarkets.com/research/n5nz4t/global_cancer

CONTACT: Research and Markets
         Laura Wood, Senior Manager
         press@researchandmarkets.com
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
         U.S. Fax: 646-607-1907
         Fax (outside U.S.): +353-1-481-1716
         Related Topics: Oncology Drugs , Clinical Trials, Dermatology

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.